Design, synthesis and biological evaluation of novel SIRT3 inhibitors targeting both NAD+ and substrate binding sites for the treatment of acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, synthesis and biological evaluation of novel SIRT3 inhibitors targeting both NAD+ and substrate binding sites for the treatment of acute myeloid leukemia

Published:2024-10 Issue: Volume:276 Page:116689
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Yang Xuetao,Ge Ge,Wang Hailing,Liu Tianli,Pan Dabo,Zhao Xi,Chen Xiya,Wang Jinhui,Zhang Jin,Zhang Ke,Yao Dahong

Funder

Shenzhen Science and Technology Innovation Committee

National Natural Science Foundation of China

Guangdong Provincial Natural Science Foundation

Publisher

Elsevier BV

Reference27 articles.

1. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML;Vetrie;Nat. Rev. Cancer,2020

2. Molecular biomarkers in acute myeloid leukemia;Prada-Arismendy;Blood Rev.,2017

3. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

4. Tracing the origins of relapse in acute myeloid leukaemia to stem cells;Shlush;Nature,2017

5. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges;Short;Cancer Discov.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP